[ad_1] Business Earnings Supply-chain and demand challenges pressure the Dublin-based company’s quarterly results [ad_2] Source link Source link
Read MoreTag: wsjhealth
[ad_1] ‘Confusing, and long, and drawn-out.’ Some hospitals make getting aid hard, delay checking eligibility and sometimes press for payments that aren’t refunded even if a patient eventually gets qualified for assistance. [ad_2] Source link Source link
Read More[ad_1] Across the industry, certain semiconductors and specialized plastics, metals and resins are hard to come by. [ad_2] Source link Source link
Read More[ad_1] The veteran pharmaceutical executive takes charge of after the failed launch of Biogen’s once-promising Alzheimer’s disease drug Aduhelm. [ad_2] Source link Source link
Read More[ad_1] The company has applied for FDA approval of Symplicity Spyral, an experimental device used to perform a minimally invasive treatment procedure. [ad_2] Source link Source link
Read More[ad_1] Cardinal Health Inc. said its top line rose 13% in its recently completed quarter, with gains for its pharmaceutical business offsetting a decline in its medical segment. [ad_2] Source link Source link
Read More[ad_1] The pharmaceutical company says its sales could be as much as $3 billion lower this year than initially expected. [ad_2] Source link Source link
Read More[ad_1] Health Johnson & Johnson wanted a deal to boost its medical-device division, which will become more important after the company sheds its consumer-health business [ad_2] Source link Source link
Read More[ad_1] Business Drugstore chain agrees to make payments over 10 years to states, cities and tribes that sued over opioid abuse [ad_2] Source link Source link
Read More[ad_1] The deal would add heart pumps, a fast-growing part of the medical-device industry, to the J&J lineup. [ad_2] Source link Source link
Read More[ad_1] Health Pfizer says results are sufficient to seek approval for the shot, which could be the first deployed against the common respiratory virus [ad_2] Source link Source link
Read More[ad_1] Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies […]
Read More[ad_1] Startups are prescribing ketamine online to treat serious mental-health conditions, raising concern among psychiatrists about the safety of taking the mind-altering anesthetic without medical supervision, sometimes at high doses that raise risks of side effects. Ketamine is approved by the Food and Drug Administration to anesthetize people and animals and has been used safely […]
Read More